Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
Pharma
Vera’s dual-target atacicept wins FDA approval for IgAN
While atacicept is the first BAFF/APRIL dual inhibitor to enter the U.S. market, Vertex's povetacicept is trailing closely.
Angus Liu
Jul 7, 2026 12:23pm
Vertex gains FDA expansion of Casgevy to those ages 2 and older
Jul 6, 2026 11:30am
Orca Bio takes commercial leap with FDA approval for Tregzi
Jul 1, 2026 12:14am
Viridian set for 1-on-1 vs. Amgen after FDA approval of Lumvoa
Jun 29, 2026 8:32am
FDA approves GSK, Spero's oral treatment for complicated UTIs
Jun 17, 2026 3:20pm
Shionogi's Japan-approved antiviral nets US COVID nod
Jun 1, 2026 11:11am
